Glycosade v UCCS in the Dietary Management of Hepatic GSD
NCT02318966 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2024-02-16
Summary
To compare efficacy of Glycosade® with uncooked corn starch (UCCS for the dietary management of hepatic glycogen storage diseases (GSD).
Conditions
- Glycogen Storage Disease
Interventions
- DIETARY_SUPPLEMENT
-
Medical Food - Glycosade
double blind randomised crossover of 2 starches - glycosade and UCCS
Sponsors & Collaborators
-
University College London Hospitals
collaborator OTHER -
University of Florida
collaborator OTHER -
Great Ormond Street Hospital for Children NHS Foundation Trust
collaborator OTHER -
University Medical Center Groningen
collaborator OTHER -
Hôpital Necker-Enfants Malades
collaborator OTHER -
Vitaflo International, Ltd
lead INDUSTRY
Principal Investigators
-
Helen Mundy, MRCP MRCPCH · Guys and St Thomas NHS Foundation Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 2 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-22
- Primary Completion
- 2020-08-14
- Completion
- 2020-08-14
Countries
- United States
- France
- Netherlands
- United Kingdom
Study Locations
More Related Trials
-
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders
NCT00718627 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Bileacid Malabsorption and GLP-1 Secretion
NCT03009916 ·Status: COMPLETED ·Phase: PHASE4
-
Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease
NCT01553500 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Minimization of IntraLipid Versus Omegaven
NCT01247012 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study)
NCT06352697 ·Status: COMPLETED ·Phase: NA
-
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 ·Status: COMPLETED ·Phase: NA
-
Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442 ·Status: TERMINATED ·Phase: NA
-
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
NCT02328768 ·Status: APPROVED_FOR_MARKETING
-
Ursodeoxycholic Acid Prevents Total Parenteral Nutrition Cholestasis
NCT05043194 ·Status: UNKNOWN ·Phase: NA
-
Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases
NCT02517385 ·Status: COMPLETED ·Phase: PHASE3
-
Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
NCT02498340 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
NCT01412359 ·Status: APPROVED_FOR_MARKETING
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Compassionate Use of Omegaven
NCT02778698 ·Status: APPROVED_FOR_MARKETING
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Steroids in Fulminant Hepatitis A in the Pediatric Age Group
NCT02375867 ·Status: COMPLETED ·Phase: PHASE4
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2
-
Liver Adiposity Effects on Pediatric Statin
NCT04903223 ·Status: RECRUITING ·Phase: PHASE1
-
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
NCT03312140 ·Status: COMPLETED ·Phase: NA
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1